医薬品新興国市場2017-2021...市場調査レポートについてご紹介

【英文タイトル】Global Pharmerging Markets 2017-2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report
• Market overview

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Highlights

PART 05: Global pharmaceutical market
• Market size and forecast

PART 06: Road to pharmerging markets

PART 07: Pharmerging markets

PART 08: Market landscape
• Medicine spending in emerging economies
• Five forces analysis

PART 09: Market segmentation by geography

PART 10: Market overview of tier I countries
• China

PART 11: Market overview of tier II countries
• Brazil
• Russia
• India

PART 12: Market overview of tier III countries
• Market size and forecast

PART 13: Market drivers
• Limitations in developed economies fuels demand in emerging economies
• Increasing focus toward biosimilar in potential areas
• Expansion initiatives of vendors

PART 14: Impact of drivers

PART 15: Market challenges
• IP protection issues
• Socio-political issues in cross geography transactions
• Stringent price control and generic-centric usage lead to value erosion

PART 16: Impact of drivers and challenges

PART 17: Market trends
• Potential of new countries in emerging markets
• Positive outlook toward adoption of targeted therapies
• Evolving stakeholder landscape to change market dynamics

PART 18: Vendor landscape
• Competitive scenario

PART 19: Key vendor analysis
• AstraZeneca
• GlaxoSmithKline
• Pfizer
• Sanofi
• Novartis
• Other prominent vendors

PART 20: Appendix
• List of Abbreviations

PART 21: Explore Technavio

[List of Exhibits]

Exhibit 01: Global country rankings in pharmaceutical market based on healthcare spending
Exhibit 02: Global pharmaceutical market 2016-2021 ($ trillions)
Exhibit 03: Drivers, challenges and trends of global pharmaceutical market
Exhibit 04: Growth comparision between developed markets and pharmerging markets
Exhibit 05: Share of pharmerging markets in global pharmaceutical market, 2016
Exhibit 06: Snapshot of key pharmerging markets
Exhibit 07: Regulatory landscape in key pharmerging markets
Exhibit 08: Pharmerging markets 2016-2021 ($ billions)
Exhibit 09: Comparison of medicine spending in developed economies and pharmerging markets
Exhibit 10: Medicine spending and growth rates in pharmerging markets
Exhibit 11: Standard units in 2021 by product type in pharmerging countries
Exhibit 12: Expected medicine spending by geography
Exhibit 13: Volume growth and population with more than $5,000/year income by country 2016
Exhibit 14: Percentage share of pharmerging markets in global pharmaceutical market 2016-2021
Exhibit 15: Percentage share of tier I, II and III countries in total pharmerging markets 2016-2021
Exhibit 16: Pharmerging markets share by country, 2016
Exhibit 17: Five forces analysis
Exhibit 18: Pharmerging markets segment by geography
Exhibit 19: Geographic representation of tier I country
Exhibit 20: China GDP 2011-2015 ($ trillions) and healthcare expenditure 2010-2014 (% of GDP)
Exhibit 21: On-going healthcare reforms in China
Exhibit 22: Segmentation of Chinese pharmaceutical market
Exhibit 23: Segment analysis in Chinese pharmaceutical market
Exhibit 24: Regulatory bodies
Exhibit 25: Major therapy areas based on sales of drugs, 2016
Exhibit 26: Major acquisitions in Chinese pharmaceutical market 2014-2016
Exhibit 27: Drivers and challenges in Chinese pharmaceutical market
Exhibit 28: Pharmaceutical market in China 2016-2021 ($ billions)
Exhibit 29: China pharmaceutical market: SWOT analysis
Exhibit 30: Geographic representation of tier II countries
Exhibit 31: Pharmaceutical market in tier II countries 2016-2021 ($ billions)
Exhibit 32: Brazil GDP 2011-2015 ($ trillions) and healthcare expenditure 2010-2014 (% of GDP)
Exhibit 33: Regulatory bodies
Exhibit 34: Segmentation of pharmaceutical market in Brazil 2016
Exhibit 35: Major acquisitions in Brazil pharmaceutical market
Exhibit 36: Drivers and challenges in Brazilian pharmaceutical market
Exhibit 37: Pharmaceutical market in Brazil 2016-2021 ($ billions)
Exhibit 38: Brazil pharmaceutical market: SWOT analysis
Exhibit 39: Russia GDP 2011-2015 ($ trillions) and healthcare expenditure 2010-2014 (% of GDP)
Exhibit 40: Major acquisitions in Russian pharmaceutical market
Exhibit 41: Drivers and challenges in Russian pharmaceutical market
Exhibit 42: Pharmaceutical market in Russia 2016-2021 ($ billions)
Exhibit 43: Russia pharmaceutical market: SWOT analysis
Exhibit 44: India GDP 2011-2015 ($ trillions) and healthcare expenditure 2010-2014 (% of GDP)
Exhibit 45: Regulatory landscape
Exhibit 46: Major acquisitions in pharmaceutical sector in India
Exhibit 47: Drivers and challenges in Indian pharmaceutical market
Exhibit 48: Pharmaceutical market in India 2016-2021 ($ billions)
Exhibit 49: India pharmaceutical market: SWOT analysis
Exhibit 50: Geographic representation of tier III countries
Exhibit 51: Pharmaceutical market in tier III countries 2016-2021 ($ billions)
Exhibit 52: Revenues from pharmaceuticals for few of the tier III countries 2016 ($ billions)
Exhibit 53: Snapshot of key countries in tier III countries
Exhibit 54: Tier III countries pharmaceutical market: SWOT analysis
Exhibit 55: Factors that are driving the growth in emerging economies
Exhibit 56: Biosimilar development in emerging economies
Exhibit 57: Few acquisitions and their impact
Exhibit 58: Impact of drivers
Exhibit 59: Impact of drivers and challenges
Exhibit 60: Positioning of key vendors in pharmerging markets 2015
Exhibit 61: Competitive analysis snapshot
Exhibit 62: Top selling products in emerging markets 2015
Exhibit 63: Key takeaways
Exhibit 64: Key highlights in emerging markets
Exhibit 65: AstraZeneca strength assessment
Exhibit 66: Geographic segmentation by revenue 2015
Exhibit 67: Key takeaways
Exhibit 68: Key highlights in emerging markets
Exhibit 69: GSK strength assessment
Exhibit 70: Geographic segmentation by revenue 2015
Exhibit 71: Key takeaways
Exhibit 72: Pfizer: YoY and growth rate in emerging markets
Exhibit 73: Segmentation by revenue in emerging markets ($ millions)
Exhibit 74: Key highlights in emerging markets
Exhibit 75: Pfizer strength assessment
Exhibit 76: Pfizer: Geographical segmentation by revenue 2015
Exhibit 77: Top selling products0
Exhibit 78: Key emerging products0
Exhibit 79: Geographical segmentation by revenue1
Exhibit 80: Key takeaways2
Exhibit 81: Key highlights in emerging markets2
Exhibit 82: Sanofi strength assessment3
Exhibit 83: Key takeaways4
Exhibit 84: Key highlights in emerging markets5
Exhibit 85: Novartis strength assessment6
Exhibit 86: Novartis: Geographical segmentation by revenue 20156


【レポート販売概要】

■ タイトル:医薬品新興国市場2017-2021
■ 英文:Global Pharmerging Markets 2017-2021
■ 発行日:2017年1月16日
■ 調査会社:Technavio
■ 商品コード:IRTNTR11577
■ 調査対象地域:ブラジル、ロシア、中国、インド、トルコ、メキシコ、韓国
  • デング熱(Dengue)の治療薬パイプライン動向(2015年上半期版)
    Dengue - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Dengue - Pipeline Review, H1 2015’, provides an overview of the Dengue’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dengue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (R …
  • フランスの病院用品市場(~2021)
    France Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Room Equipment, Patient Examination Devices, Sterilization Equipment and Syringes and Needles Summary GlobalData’s new report, "France Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Room …
  • 皮膚B細胞リンパ腫:世界の臨床試験レビュー(2014年上半期)
    Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the Cutaneous B-Cell Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cutaneous B-Cell Lymphoma. It includes an overview of the trial …
  • IT資産処分(ITAD)の世界市場予測:逆製造&リサイクル、リマーケティング&価値回収、データ破壊・データサニタイゼーション、静脈物流&物流管理
    The IT asset disposition market is expected to reach USD 20.09 Billion by 2022, at a CAGR of 9.83% during the forecast period. The performance and characteristics of IT asset disposition depend largely upon the services offered. The IT asset disposition market has penetrated several industries due to the large number of standard regulatory compliances as well as the increasing focus on environment …
  • 集光型太陽光発電の世界市場(~2019)
    This report estimates the concentrated photovoltaic market in terms of value. The global concentrated photovoltaic market is segmented based on their concentration levels, which include high, medium, and low. The market is further segmented on the basis of regions such as Asia-Pacific, Europe, the Middle East & Africa, and Americas as well as on the basis of technologies such as refractors and ref …
  • カロテノイドの世界市場分析:由来別(天然、合成)、製品別(ベータカロテン、ルテイン、リコペン、アスタキサンチン、ゼアキサンチン、カンタキサンチン)、用途別(食品、サプリメント、飼料、医薬品、化粧品)、セグメント予測、2014-2025
    The global carotenoids market is expected to reach USD 1.74 billion by 2025, according to a new report by Grand View Research, Inc. The growing application in human food, animal feed, dietary supplements, medicines, and cosmetic application owing to the presence of essential nutrients and vitamins in carotenoids will drive growth over the upcoming years. Furthermore, the increasing demand for thes …
  • Uveitis:市場分析及び予測(~2017)
    OpportunityAnalyzer: Uveitis - Opportunity Analysis and Forecasts to 2017 Summary Uveitis is an expanding market currently dominated by corticosteroid treatment options as well as off-label immunosuppressive and biologic drugs. Since the conventional corticosteroid treatment is only effective in 50-60% of patients a significant number of patients can be targeted with the new treatment options. Whi …
  • ウェアラブルパッチの世界市場2016-2020:通常ウェアラブルパッチ、コネクテッドウェアラブルパッチ
    About Wearable Patches Wearable patches can be affixed to the skin and can be worn for a few hours to a couple of weeks. These patches are used for the treatment and delivery of medications such as nicotine. They are also used as anti-aging patches. The connected wearable patches feature wireless connectivity, in addition to the features of regular wearable patches, which help in monitoring the he …
  • 2つのエチルヘキサノール (2-EH)の世界市場予測
    2-Ethylhexanol (2-EH) 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about 2-Ethylhexanol (2-EH) market in the all-in-one report issued in a logical and easily accessible format. In addition to t …
  • 車両接近通報装置(AVAS)の世界市場予測(~2027年)
    “Government mandate for implementation of acoustic vehicle alerting system is significant factors for the growth of the acoustic vehicle alerting system market globally”The acoustic vehicle alerting system market is projected to reach USD 5,615 million by 2027 from an estimated USD 425 million in 2019 considering the installation of AVAS in passenger car and commercial vehicle, at a CAGR of 38.1% …
  • 米国の石炭液化産業分析:Coal Liquefaction Industry in United States
    The tightening of worldwide oil reserves is causing the price of oil to escalate - and makes coal, which is much more abundantly available, an interesting starting material for liquid fuels and chemical raw materials. Circumstances have thus made coal liquefaction a very lucrative option. Coal liquefaction is a process that converts coal from a solid state into liquid fuels, usually to provide sub …
  • Nordic Storage AB:石油・ガスバリューチェーン分析レポート2013
    Nordic Storage AB Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Nordic Storage AB" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Nordic Storage AB”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the …
  • Bill Barrett Corporation:石油・ガスの開発・生産動向及びコスト分析– Q1, 2013
    Bill Barrett Corporation Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary Bill Barrett Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
  • オフグリッド・エネルギー貯蔵システムの世界市場2016-2020
    About Off-Grid Power Generation Systems Off-grid power generation systems are generally used when there are capital limitations or the physical landscape makes it tough to have a grid connection. Off-grid energy storage systems are used in localities that are far away from populated areas or cities and not connected to any electricity grid. In these regions, despite the presence of independent pow …
  • 世界の砂糖市場(~2019)
    The expansion of the global sugar industry is forecast to reach 0.8% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 6.5%. Currently, solid refined sugar accounts for 38.7% of the global demand while the remaining market share is divided between raw cane sugar (49.4%), molasses (9.6%), maple syrup and maple sugar (1.5%) and raw beet sugar (0.8% …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。